Position paper for the organization of ECMO programs for cardiac failure in adults

for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO)

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalIntensive Care Medicine
DOIs
StateAccepted/In press - Feb 15 2018

Fingerprint

Extracorporeal Membrane Oxygenation
Heart Failure
Patient Care
Patient Transfer
Heart-Assist Devices
Cardiogenic Shock
Cardiopulmonary Resuscitation
Heart Transplantation
Heart Arrest
Practice Guidelines
Respiratory Insufficiency
Patient Selection
Cardiac Arrhythmias
Therapeutics
Technology
Equipment and Supplies
Population

Keywords

  • Cardiac arrest
  • Cardiac failure
  • Critical care networks
  • Extracorporeal life support
  • Extracorporeal membrane oxygenation
  • Hospital organization
  • Mechanical circulatory support
  • Position article

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO) (Accepted/In press). Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Medicine, 1-13. https://doi.org/10.1007/s00134-018-5064-5

Position paper for the organization of ECMO programs for cardiac failure in adults. / for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO).

In: Intensive Care Medicine, 15.02.2018, p. 1-13.

Research output: Contribution to journalArticle

for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO) 2018, 'Position paper for the organization of ECMO programs for cardiac failure in adults', Intensive Care Medicine, pp. 1-13. https://doi.org/10.1007/s00134-018-5064-5
for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO). Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Medicine. 2018 Feb 15;1-13. https://doi.org/10.1007/s00134-018-5064-5
for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO). / Position paper for the organization of ECMO programs for cardiac failure in adults. In: Intensive Care Medicine. 2018 ; pp. 1-13.
@article{18475356d52a4060a36cfff29f4a915f,
title = "Position paper for the organization of ECMO programs for cardiac failure in adults",
abstract = "Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.",
keywords = "Cardiac arrest, Cardiac failure, Critical care networks, Extracorporeal life support, Extracorporeal membrane oxygenation, Hospital organization, Mechanical circulatory support, Position article",
author = "{for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO)} and Darryl Abrams and Garan, {A. Reshad} and Akram Abdelbary and Matthew Bacchetta and Bartlett, {Robert H.} and James Beck and Jan Belohlavek and Chen, {Yih Sharng} and Eddy Fan and Ferguson, {Niall D.} and Fowles, {Jo anne} and John Fraser and Gong, {Michelle Ng} and Hassan, {Ibrahim F.} and Carol Hodgson and Xiaotong Hou and Katarzyna Hryniewicz and Shingo Ichiba and Jakobleff, {William A.} and Roberto Lorusso and Graeme MacLaren and Shay McGuinness and Thomas Mueller and Park, {Pauline K.} and Peek, {Giles J.} and Vin Pellegrino and Susanna Price and Rosenzweig, {Erika B.} and Tetsuya Sakamoto and Leonardo Salazar and Matthieu Schmidt and Slutsky, {Arthur S.} and Christian Spaulding and Hiroo Takayama and Koji Takeda and Alain Vuylsteke and Alain Combes and Daniel Brodie",
year = "2018",
month = "2",
day = "15",
doi = "10.1007/s00134-018-5064-5",
language = "English (US)",
pages = "1--13",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Position paper for the organization of ECMO programs for cardiac failure in adults

AU - for The International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO)

AU - Abrams, Darryl

AU - Garan, A. Reshad

AU - Abdelbary, Akram

AU - Bacchetta, Matthew

AU - Bartlett, Robert H.

AU - Beck, James

AU - Belohlavek, Jan

AU - Chen, Yih Sharng

AU - Fan, Eddy

AU - Ferguson, Niall D.

AU - Fowles, Jo anne

AU - Fraser, John

AU - Gong, Michelle Ng

AU - Hassan, Ibrahim F.

AU - Hodgson, Carol

AU - Hou, Xiaotong

AU - Hryniewicz, Katarzyna

AU - Ichiba, Shingo

AU - Jakobleff, William A.

AU - Lorusso, Roberto

AU - MacLaren, Graeme

AU - McGuinness, Shay

AU - Mueller, Thomas

AU - Park, Pauline K.

AU - Peek, Giles J.

AU - Pellegrino, Vin

AU - Price, Susanna

AU - Rosenzweig, Erika B.

AU - Sakamoto, Tetsuya

AU - Salazar, Leonardo

AU - Schmidt, Matthieu

AU - Slutsky, Arthur S.

AU - Spaulding, Christian

AU - Takayama, Hiroo

AU - Takeda, Koji

AU - Vuylsteke, Alain

AU - Combes, Alain

AU - Brodie, Daniel

PY - 2018/2/15

Y1 - 2018/2/15

N2 - Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.

AB - Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.

KW - Cardiac arrest

KW - Cardiac failure

KW - Critical care networks

KW - Extracorporeal life support

KW - Extracorporeal membrane oxygenation

KW - Hospital organization

KW - Mechanical circulatory support

KW - Position article

UR - http://www.scopus.com/inward/record.url?scp=85042090080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042090080&partnerID=8YFLogxK

U2 - 10.1007/s00134-018-5064-5

DO - 10.1007/s00134-018-5064-5

M3 - Article

SP - 1

EP - 13

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

ER -